Gross margin moved 1709 bp lower
Gross margin changed -1709 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
33.24%→16.15%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RCAT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 205.6%
Operating income changed -205.6% from the comparable as-filed period.
-$12.6M→-$38.6M1 prior comparisons
Operating margin moved 92943 bp higher
Operating margin changed +92943 basis points from the comparable as-filed period.
-1120.85%→-191.42%1 prior comparisons
Research & development increased 295.2%
Research & development changed +295.2% from the comparable as-filed period.
$3.6M→$14.2M2 prior comparisons
Cost of revenue increased 495.4%
Cost of revenue changed +495.4% from the comparable as-filed period.
$2.8M→$16.9M2 prior comparisons
Shares outstanding increased 53.1%
Shares outstanding changed +53.1% from the comparable as-filed period.
99,764,256→152,714,3623 prior comparisons
Trade receivables increased 842.5%
Trade receivables changed +842.5% from the comparable as-filed period.
$1.0M→$9.5M2 prior comparisons
Gross profit increased 769.2%
Gross profit changed +769.2% from the comparable as-filed period.
$375,054→$3.3M2 prior comparisons
Stock-based compensation increased 147.8%
Stock-based compensation changed +147.8% from the comparable as-filed period.
$2.0M→$5.0M3 prior comparisons
Current assets increased 364.2%
Current assets changed +364.2% from the comparable as-filed period.
$91.6M→$425.1M2 prior comparisons
Inventory increased 353.9%
Inventory changed +353.9% from the comparable as-filed period.
$16.2M→$73.4M2 prior comparisons
Total assets increased 334.6%
Total assets changed +334.6% from the comparable as-filed period.
$121.4M→$527.5M2 prior comparisons
Working capital increased 487.9%
Working capital changed +487.9% from the comparable as-filed period.
$67.4M→$396.5M2 prior comparisons
SBC / revenue moved 15539 bp lower
SBC / revenue changed -15539 basis points from the comparable as-filed period.
180.37%→24.97%1 prior comparisons
Inventory / revenue moved 106960 bp lower
Inventory / revenue changed -106960 basis points from the comparable as-filed period.
1433.11%→363.51%1 prior comparisons
Current liabilities increased 18.6%
Current liabilities changed +18.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$24.1M→$28.6M2 prior comparisons
Revenue changed across a low base
Revenue changed +1689.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$1.1M→$20.2M2 prior comparisons
Short-term borrowings increased 154.9%
Short-term borrowings changed +154.9% from the comparable as-filed period.
$350,000→$892,0002 prior comparisons
Capex / revenue moved 143 bp higher
Capex / revenue changed +143 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.17%→28.60%2 prior comparisons
Current ratio increased 291.5%
Current ratio changed +291.5% from the comparable as-filed period.
3.8→14.862 prior comparisons
R&D / revenue moved 24848 bp lower
R&D / revenue changed -24848 basis points from the comparable as-filed period.
318.91%→70.43%2 prior comparisons
Working capital / assets moved 1960 bp higher
Working capital / assets changed +1960 basis points from the comparable as-filed period.
55.57%→75.17%2 prior comparisons
Receivables / revenue moved 4247 bp lower
Receivables / revenue changed -4247 basis points from the comparable as-filed period.
89.73%→47.27%1 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +1783.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$306,523→$5.8M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.